The Pharma Letter

Bayer’s Mirena enters Phase III study for NAEH

German pharma major Bayer has announced the start of its Phase III study SUNFLOWER, an investigational study evaluating the ...
Pharmabiz

Bayer initiates phase III study SUNFLOWER with long-acting reversible intrauterine system ...

Bayer initiates phase III study SUNFLOWER with long-acting reversible intrauterine system for treatment of nonatypical endometrial hyperplasia: Berlin Wednesday, December 3, 2025, ...
Everyday Health on MSN

What Are the Best Birth Control Options?

There are pros and cons for every kind of contraception. Learn which are the most effective and what is the best option for ...

Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial ...

Bayer announced today the start of its Phase III study SUNFLOWER, an investigational study evaluating the efficacy and safety ...
Medical Dialogues

Bayer begins Phase III study with Mirena for nonatypical endometrial hyperplasia

Berlin: Bayer has announced the clinical Phase III study SUNFLOWER with its 52mg levonorgestrel-releasing intrauterine system ...